Biomechanics in Regenerative Medicine (BiRM) Training Program
再生医学生物力学 (BiRM) 培训计划
基本信息
- 批准号:10628407
- 负责人:
- 金额:$ 22.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
This is a new application for continued support of a unique, vibrant, multi-institutional and multi-disciplinary pre-
doctoral training program entitled “Biomechanics in Regenerative Medicine (BiRM)” jointly run by the
Departments of Bioengineering at the University of Pittsburgh and Biomedical Engineering at Carnegie Mellon
University. For the past 16 years, 38 trainees have gained a solid foundation that has led to independent careers
in academia (n=10), industry (n=24), and government (n=4) with an additional seven (7) trainees currently
enrolled. BiRM is an innovative training program with an in depth focus on multi-scale biomechanics as applied
to regenerative medicine for the development or repair of tissues (and organs?) whose primary physiological
function is mechanical. As the field of regenerative medicine matures, it is necessary to arm the next generation
engineering workforce with a deeper understanding of multi-scale biomechanics, the relationship between
biomechanics and growth and remodeling (mechanobiology), and the biological basis of repair and regeneration.
To accomplish these, we will also hone our trainees with skills in contemporary engineering technologies (e.g.,
artificial intelligence (AI), mechatronics, robotics, computation, process control, and manufacturing). BiRM
leverages the didactic and research experiences of distinct strengths and resources of two major universities
plus clinical experience of a World-class medical center all located adjacent to one another without administrative
roadblocks in conventional cross-institutional programs.
Trainee candidates are primarily from bioengineering, but we also welcome those from other disciplines. Another
unique aspect of BiRM is the significant clinical exposure for trainees (including a mandatory clinical mentor) to
aid in appreciation of the enormous potential, opportunity, and challenge of translating regenerative medicine
technologies. Similarly, challenges and opportunities in biomanufacturing and large-scale production of
regenerative medicine technologies will be imparted to the trainees with our unique partnership with the
Advanced Regenerative Manufacturing Institute. Professional and career development are offered, including
innovation and entrepreneurship.
In the next five years, we aim to maintain 6 pre-doctoral fellowships per year. Our multi-institutional program will
provide a unique opportunity for our trainees to 1) develop key collaborative and multidisciplinary skills on multi-
scale biomechanics, 2) to prepare them to enter the future regenerative medicine workforce as the field moves
from conception to reality, and 3) to become innovators in upstream research and downstream production for
the next generation of technologies.
这是一个新的应用程序,旨在持续支持独特的、充满活力的、多机构和多学科的预科项目。
与中科院联合举办“再生医学生物力学(BiRM)”博士生培养项目
匹兹堡大学生物工程系和卡内基梅隆大学生物医学工程系
大学。 16年来,38名学员奠定了独立职业生涯的坚实基础
在学术界 (n=10)、工业界 (n=24) 和政府 (n=4),目前还有七 (7) 名学员
已注册。 BiRM 是一项创新培训计划,深入关注多尺度生物力学的应用
再生医学用于发育或修复其主要生理功能的组织(和器官?)
功能是机械的。随着再生医学领域的成熟,需要武装下一代
工程人员对多尺度生物力学、之间的关系有更深入的了解
生物力学、生长和重塑(力学生物学),以及修复和再生的生物学基础。
为了实现这些目标,我们还将磨练学员当代工程技术的技能(例如,
人工智能 (AI)、机电一体化、机器人、计算、过程控制和制造)。 BiRM
利用两所主要大学的独特优势和资源的教学和研究经验
加上世界一流医疗中心的临床经验,这些中心彼此相邻,无需行政管理
传统跨机构项目的障碍。
实习生候选人主要来自生物工程,但我们也欢迎来自其他学科的人。其他
BiRM 的独特之处在于受训者(包括强制性临床导师)有大量的临床经验
帮助认识转化再生医学的巨大潜力、机遇和挑战
技术。同样,生物制造和大规模生产的挑战和机遇
再生医学技术将通过我们与
先进再生制造研究所。提供专业和职业发展,包括
创新创业。
未来五年,我们的目标是保持每年 6 个博士前奖学金。我们的多机构计划将
为我们的学员提供独特的机会:1)培养多方面的关键协作和多学科技能
规模生物力学,2) 让他们做好准备,随着该领域的发展进入未来的再生医学队伍
从构想到现实,3)成为上游研究和下游生产的创新者
下一代技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Alan Vorp其他文献
Finite element modelling and analyses of nonlinearly elastic, orthotropic, vascular tissue in distension
- DOI:
10.1007/bf02368653 - 发表时间:
1993-11-01 - 期刊:
- 影响因子:5.400
- 作者:
David Alan Vorp - 通讯作者:
David Alan Vorp
David Alan Vorp的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Alan Vorp', 18)}}的其他基金
A Machine Learning-Based Clinical Decision Support Tool to Predict Abdominal Aortic Aneurysm Prognosis Using Existing Longitudinal Data
基于机器学习的临床决策支持工具,利用现有纵向数据预测腹主动脉瘤预后
- 批准号:
10331850 - 财政年份:2021
- 资助金额:
$ 22.23万 - 项目类别:
A Machine Learning-Based Clinical Decision Support Tool to Predict Abdominal Aortic Aneurysm Prognosis Using Existing Longitudinal Data
基于机器学习的临床决策支持工具,利用现有纵向数据预测腹主动脉瘤预后
- 批准号:
10115365 - 财政年份:2021
- 资助金额:
$ 22.23万 - 项目类别:
The Role of Fibrinolysis in Tissue Engineered Vascular Grafts for Aged Individuals
纤溶在老年人组织工程血管移植中的作用
- 批准号:
9979086 - 财政年份:2020
- 资助金额:
$ 22.23万 - 项目类别:
Preclinical optimization and design for manufacturability of immunoregulatory tissue-engineered vascular grafts
免疫调节组织工程血管移植物可制造性的临床前优化和设计
- 批准号:
10054024 - 财政年份:2020
- 资助金额:
$ 22.23万 - 项目类别:
Artificial Stem Cells for Vascular Tissue Engineering
用于血管组织工程的人工干细胞
- 批准号:
9175164 - 财政年份:2016
- 资助金额:
$ 22.23万 - 项目类别:
Artificial Stem Cells for Vascular Tissue Engineering
用于血管组织工程的人工干细胞
- 批准号:
9276786 - 财政年份:2016
- 资助金额:
$ 22.23万 - 项目类别:
An Autologous, Culture-Free, Adipose Cell-Based Tissue Engineered Vascular Graft
一种自体、无培养、基于脂肪细胞的组织工程血管移植物
- 批准号:
9015874 - 财政年份:2016
- 资助金额:
$ 22.23万 - 项目类别:
An Autologous, Culture-Free, Adipose Cell-Based Tissue Engineered Vascular Graft
一种自体、无培养、基于脂肪细胞的组织工程血管移植物
- 批准号:
9260065 - 财政年份:2016
- 资助金额:
$ 22.23万 - 项目类别:
Autologous Stem Cell-Based Tissue Engineered Vascular Grafts
基于自体干细胞的组织工程血管移植物
- 批准号:
8426531 - 财政年份:2013
- 资助金额:
$ 22.23万 - 项目类别:
相似海外基金
NSF Engines: Piedmont Triad Regenerative Medicine Engine
NSF 引擎:Piedmont Triad 再生医学引擎
- 批准号:
2315654 - 财政年份:2024
- 资助金额:
$ 22.23万 - 项目类别:
Cooperative Agreement
I-Corps: Technology for processing lipoaspirate for plastic surgery and regenerative medicine
I-Corps:用于整形外科和再生医学的脂肪抽吸物处理技术
- 批准号:
2343782 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Standard Grant
Market Feasibility for a Engineering Biology Approach to Cell Therapy for Brain Cancer and Regenerative Medicine
脑癌和再生医学细胞治疗的工程生物学方法的市场可行性
- 批准号:
10074920 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Grant for R&D
Non-invasive assessment of 3D tissue constructs for regenerative medicine and cell transplantation
用于再生医学和细胞移植的 3D 组织结构的非侵入性评估
- 批准号:
23H03782 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel accelerated maturation method of hiPSC-derived cardiomyocytes: research for heart regenerative medicine
hiPSC 来源的心肌细胞的新型加速成熟方法的开发:心脏再生医学研究
- 批准号:
23K08265 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Animal Free Structured Collagens for Regenerative Medicine
用于再生医学的无动物源结构化胶原蛋白
- 批准号:
10076142 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Grant for R&D
Clickable Extracellular Vesicles to Silk-Based Biomaterials for Regenerative Medicine
用于再生医学的可点击细胞外囊泡到丝基生物材料
- 批准号:
10642420 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Translational Nonhuman Primate Regenerative Medicine and Gene Therapy/Genome Editing Resource Program
转化非人类灵长类再生医学和基因治疗/基因组编辑资源计划
- 批准号:
10889393 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Establishment of basic technology for the development of veterinary regenerative medicine products using clinically applicable canine iPS cells
建立利用临床适用的犬iPS细胞开发兽用再生医学产品的基础技术
- 批准号:
23H02388 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regenerative Medicine Research on Osteo-related Tissues of Spondylo-Dysplastic Ehlers–Danlos Syndrome Type 3 (EDSSPD3) with a point mutation of SLC39A13 Zinc Transporter Gene
埃勒斯脊柱发育不良骨相关组织的再生医学研究
- 批准号:
23K06510 - 财政年份:2023
- 资助金额:
$ 22.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




